Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Pfizer Inc (PFE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
25.60 -0.23    -0.89%
03/05 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US7170811035 
S/N:  852009
  • Volume: 6,480
  • Bid/Ask: 25.84 / 25.86
  • Day's Range: 25.60 - 26.06
Pfizer 25.60 -0.23 -0.89%

PFE Balance Sheet

 
Featured here, the Balance Sheet for Pfizer Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
01/10
2023
02/07
Total Current Assets - 43333 74012 73347
Cash and Short Term Investments 12690 12690 44182 44785
Cash - - - -
Cash & Equivalents - 2853 3148 2632
Short Term Investments - 9837 41033 42153
Total Receivables, Net - 15155 15003 13425
Accounts Receivables - Trade, Net - 11177 11086 10231
Total Inventory - 10189 10204 10310
Prepaid Expenses - - - -
Other Current Assets, Total - 5299 4623 4827
Total Assets - 226501 215021 220168
Property/Plant/Equipment, Total - Net - 21864 17862 17488
Property/Plant/Equipment, Total - Gross - 37909 33641 33042
Accumulated Depreciation, Total - -16045 -15779 -15554
Goodwill, Net - 67783 51527 51572
Intangibles, Net - 64900 40224 41406
Long Term Investments - 15382 14113 14945
Note Receivable - Long Term - 3978 3917 3194
Other Long Term Assets, Total - 11439 8933 13149
Other Assets, Total - 11970 49208 52126
Total Current Liabilities - 47794 31136 34647
Accounts Payable - 6710 5338 6081
Payable/Accrued - - - -
Accrued Expenses - 9224 7891 7252
Notes Payable/Short Term Debt - 8096 298 420
Current Port. of LT Debt/Capital Leases - 2797 2254 3580
Other Current liabilities, Total - 20967 15355 17314
Total Liabilities - 137213 117817 120875
Total Long Term Debt - 61813 61581 61674
Long Term Debt - 61813 61581 61674
Capital Lease Obligations - - - -
Deferred Income Tax - 640 1125 1232
Minority Interest - 274 270 274
Other Liabilities, Total - 18596 23407 22628
Total Equity 89288 89288 97204 99293
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - 478 478 478
Additional Paid-In Capital - 92631 92496 92329
Retained Earnings (Accumulated Deficit) - 118353 126411 128796
Treasury Stock - Common - -114487 -114485 -114482
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 89288 -7687 -7696 -7828
Total Liabilities & Shareholders' Equity - 226501 215021 220168
Total Common Shares Outstanding 5646 5646 5646 5645
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PFE Comments

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ivo Stoykov
Ivo Stoykov 19 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
At 6.1 positive carry will buy with great pleasure
DANIEL V
DANIEL V 20 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sale
Ivo Stoykov
Ivo Stoykov 19 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
kris lemey
kris lemey May 02, 2024 2:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
zijn er van Puurs pfizer bouwt enorm bij, grootse plannen.
MOSHE LION
MOSHE LION May 02, 2024 12:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
short
Faris Tubishat
Faris Tubishat May 02, 2024 12:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why earning was good and stock price is the same before 10 years where the profit was 5 billion not 15 will go up pifzer is a strong old company and have a great reputation and now they have new drugs approved
Faris Tubishat
Faris Tubishat May 01, 2024 8:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think by the end of this year's will reach 40
shortseller Best
shortseller Best May 01, 2024 8:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pfizer is a great stock to short because it has a terrible management team, like the worst CEO ever. It's extremely difficult for Pfizer to go higher. So, why buy it?
ollie susnea
ollie susnea May 01, 2024 8:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Are u on sell. Big mistake
Aa Ro
Aa Ro May 01, 2024 8:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
stable generous dividends, a promiding drug pipeline.
Scott Ross
Scott Ross May 01, 2024 8:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You missed your chance to short it. At these levels I would be a big buyer. An enormous amount of bad news has been priced into the stock. Pfizer is still a well respected drug company.
Tony Soprano
Tony Soprano May 01, 2024 8:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
gap at 38.28 is a potential fill.
DANIEL V
DANIEL V May 01, 2024 8:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
DANIEL V
DANIEL V May 01, 2024 7:23AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
pfe excellent report
Mike Nordic
MikeNordic May 01, 2024 7:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Crushed earnings! Unbelievable that the company makes 50% more money than 5 years ago but still trades at the same price. This is an easy 50% upside when the street realizes the story
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email